Skip to main content

Advertisement

Log in

Acute invasive fungal rhinosinusitis: our 2 year experience and outcome analysis

  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Purpose

The incidence of Acute invasive fungal rhinosinusitis (AIFRS) is on the rise considering the multitude of comorbidities present in a single patient.The delay in suspecting the fungal etiology, presentation of the patient for an Otorhinolaryngology consult and lack of defined protocols affects outcome.This study looks in to the various aspects of treatment of AIFRS including sample collection, diagnosis and medicosurgical treatment. We propose a protocol for the management of these patients crafted from our outcome.

Methods

Between September 2015–September 2017, 14 patients presented with AIFRS. Targeted samples were taken for Potassium hydroxide mount, histopathological studies and fungal culture. Management was initiated with antifungals and multi-approach surgical debridement.

Results

Six of these patients had multiple comorbidities and most were uncontrolled diabetics. The average delay in presentation was 9 days. Potassium hydroxide mount was the screening test of choice. A minimum of two sittings of debridement was essential. In an average follow-up period of 15.12 months, all the patients are alive and disease free.

Conclusion

A high index of suspicion, awareness among medical fraternity and precise sample collection aids a firm diagnosis. Simultaneous initiation of surgical debridement and anti-fungals is fundamental.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

AIFRS:

Acute invasive fungal rhinosinusitis

AmB:

Amphotericin B

AE:

Anterior ethmoidotomy

BA:

Bronchial asthma

CKD:

Chronic kidney disease

CT:

Computerized tomography

DKA:

Diabetic ketoacidosis

DNE:

Diagnostic nasal endoscopy

FS:

Frontal sinus

FESS:

Functional endoscopic sinus surgery

HPE:

Histopathological examination

HTN:

Hypertension

IT:

Inferior turbinate

IHD:

Ischemic heart disease

LP:

Lamina papyracea

Lip AmB:

Liposomal amphotericin B

MS:

Maxillary sinus

MMA:

Middle meatal antrostomy

MT:

Middle turbinate

MPGN:

Membranoproliferative glomerulonephritis

NLD:

Nasolacrimal duct

Pin :

Posaconazole

PE:

Posterior ethmoidotomy

KOH mount:

Potassium hydroxide mount

T1DM:

Type 1 diabetes mellitus

T2DM:

Type 2 diabetes mellitus

ST:

Superior turbinate

V:

Voricanazole

References

  1. Spielberg B, Walsh TJ, Kontoyiannis DP, Edwards J Jr, Ibrahim AS (2009) Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis 48(12):1743–1751. https://doi.org/10.1086/599105

    Article  CAS  Google Scholar 

  2. Payne SJ, Mitzner R, Kunchala S, Roland L, McGinn JD (2016) Acute invasive fungal rhino sinusitis: a 15-year experience with 41 patients. Otolaryngol Head Neck Surg 154(4):759–764

    Article  PubMed  Google Scholar 

  3. Kasapoglu F, Coskun H, Ozmen OA, Akalin H, Ener B (2010) Acute invasive fungal rhinosinusitis: evaluation of 26 patients treated with endonasal or open surgical procedures. Otolaryngol Head Neck Surg 143:614–620

    Article  PubMed  Google Scholar 

  4. Monroe MM, McLean M, Sautter N, Wax MK, Andersen PE, Smith TL, Gross ND (2013) Invasive fungal rhino sinusitis: a 15 year experience with 29 patients. The Laryngoscope 123:1583–1587

    Article  PubMed  Google Scholar 

  5. Turner JH, Soudry E, Nayak JV, Hwang PH (2013) Survival outcomes in acute invasive fungal sinusitis; a systematic review and quantitative synthesis of published evidence. The Laryngoscope 123:1112–1118

    Article  PubMed  Google Scholar 

  6. Kolekar JS (2015) Rhinocerebral mucormycosis: a retrospective study. Indian J Otolaryngol Head Neck Surg 67:93–96

    Article  PubMed  Google Scholar 

  7. Bala K, Chander J, Handa U, Punia RS, Attri AK (2015) A prospective study of mucormycosis in north India: Experience from a tertiary care hospital. Med Mycol 53:248–257

    Article  PubMed  Google Scholar 

  8. Richardson MD, Kahkola PK, Shankland GS (2003) Rhizopus, rhizomucor, absidia, and other agents of systemic and subcutaneous zygomycoses. In: Murray PR, Baron EJ, Jorgensen JH et al (eds) Manual of clinical microbiology. ASM Press, Washington, DC, pp 1761–1780

    Google Scholar 

  9. Mahomeda S, Basanth S, Mlisana K (2015) The successful use of amphotericin B followed by oral posaconazole in a rare case of invasive fungal sinusitis caused by co-infection with mucormycosis and aspergillus. IDCases 2:116–117

    Article  Google Scholar 

  10. Akdag M, Bozkurt F, Alabalik U, Hattapoglu S, Ramazan GUN (2014) Does affect combination of surgery with antifungal therapy prolong life in a mucormycosis of sino-nasal? A case report. Int Arch Med Res 6(2):26–35

    Google Scholar 

  11. Kaazak E, Aslan E, Akalin H, Saraydaroglu O, Hakyemez B, Erisen L (2013) A Mucormycosis case treated with combination of capsofungin and amphotericin B. J Mycale Med 23:179–184

    Article  Google Scholar 

  12. Parikh SL, Venkatraman G, DelGaudio JM (2004) Invasive fungal sinusitis: a 15-year review from a single institution. Am J Rhinol 18(2):75–81

    Article  PubMed  Google Scholar 

  13. Cho H-J, Jang M-S, Hong SD, Chung S-K, Kim HY, Dhong H-J (2015) Prognostic factors for survival in patients with acute invasive fungal rhino sinusitis. Am J Rhinol Allergy 29(1):48–53

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nita Rachel Rajan.

Ethics declarations

Conflict of interest

We have no conflicts of interest to declare.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and or national research committee and with 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

This was a retrospective chart review and thus informed consent was not required by our human ethics board.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shanbag, R., Rajan, N.R. & Kumar, A. Acute invasive fungal rhinosinusitis: our 2 year experience and outcome analysis. Eur Arch Otorhinolaryngol 276, 1081–1087 (2019). https://doi.org/10.1007/s00405-019-05288-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-019-05288-w

Keywords

Navigation